ADC map analysis of salivary gland tumors
Diagnosis | No. of Patients | ADCs (× 10−3 mm2/s) | |||
---|---|---|---|---|---|
Extremely Low | Low | Intermediate | High | ||
Benign | 22 | 23 ± 26 | 13 ± 11 | 33 ± 21 | 30 ± 23* |
Pleomorphic adenoma | 11 | 0 | 1 | 45 | 54 |
Warthin tumor | 10 | 50 | 22 | 20 | 8 |
Papillary cystadenoma | 1 | 0 | 9 | 64 | 28 |
Malignant | 9 | 36 ± 41 | 41 ± 32 | 20 ± 19 | 4 ± 8* |
Mucoepidermoid carcinoma | 2 | 9 | 77 | 14 | 0 |
Adenoid cystic carcinoma | 2 | 11 | 74 | 13 | 3 |
Salivary duct carcinoma | 1 | 10 | 64 | 26 | 0 |
Adenocarcinoma | 1 | 24 | 42 | 32 | 3 |
Lymphoma | 2 | 98 | 2 | 0 | 0 |
Carcinoma ex pleomorphic adenoma | 1 | 5 | 35 | 38 | 22 |
Note:—ADC indicates apparent diffusion coefficient.
Data are proportions of each of the areas having an indicated ADC level relative to the maximum tumor area on ADC maps and are expressed as means or means ± S.E.
* Statistically significant (P < 0.001, Mann-Whitney U test).